Malden, MA – According to filings with the U.S. Securities and Exchange Commission, Axiomed is raising $12,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Aditya Humad played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Axiomed
AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. We passionately believe that next-generation lumbar and cervical total disc replacement (TDR) technology will transform the lives of patients on a global scale. Led by an experienced surgeon team utilizing patented viscoelastic polymer technology, AxioMed is developing the next generation of artificial discs. Focusing on restoration of the natural function of the spine, AxioMed will enhance human health through research, innovation, development and service world-wide.

To learn more about Axiomed, visit http://www.axiomed.com/

Contact:
Aditya Humad, Chief Financial Officer
978-236-7984
ahumad@axiomed.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved